Three-Year Outcomes in Kidney Transplant Patients Randomized to Steroid-Free Immunosuppression or Steroid Withdrawal, with Enteric-Coated Mycophenolate Sodium and Cyclosporine: The Infinity Study
Figure 2
Kaplan-Meier estimates of the probability of remaining free from (a) treatment failure (BPAR (central review), graft loss, death, or loss to follow-up) or (b) BPAR.